Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL (Q74063860)
scientific article published on 01 June 2001
Language:
(P31) (Q13442814)
(P304) 586-595
(P433) 6
(P478) 86
(P577) Friday, June 1, 2001
(P921) (Q974135)
(P1433) (Q5638209)
(P1476) "Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL" (language: en)
(P2093) J J Ortega
J M Ribera
A Oriol
P Bastida
M E González
C Calvo
I Egurbide
J M Hernández Rivas
C Rivas
A Alcalá
J Besalduch
J Maciá
S Gardella
M Carnero
J M Lite
F Casanova
M Martinez
M Fontanillas
E Feliu
J F San Miguel
PETHEMA Group, Spanish Society of Hematology. Programa para el Estudio y Tratamiento de las Hemopatías Malignas
other details
description scientific article published on 01 June 2001

External Links